Background. Thyroidectomy and parathyroidectomy are the most commonly performed endocrine operations, and are increasingly being completed on a same-day basis; however, few data exist regarding the outpatient postoperative pain requirement of these patients. We aimed to describe the outpatient narcotic medication needs for patients undergoing thyroid and parathyroid surgery, and to identify predictors of higher requirement. Method. We examined patients undergoing thyroid and parathyroid surgery at two large academic institutions from 1 January-30 May 2014. Prospective data were collected on pain scores and the oral morphine equivalents (OMEQs) taken by these patients by their postoperative visit. Results. Overall, 313 adult patients underwent thyroidectomy or parathyroidectomy during the study period; 83% of patients took ten or fewer OMEQs, and 93% took 20 or fewer OMEQs. Patients who took more than ten OMEQs were younger (p \ 0.001) and reported significantly higher overall mean pain scores at their postoperative visit (p \ 0.001) than patients who took fewer than ten OMEQs. A multivariate model was constructed on pre-and intraoperative factors that may predict use of more than ten OMEQs postoperatively. Age \45 years (p = 0.002), previous narcotic use (p = 0.037), and whether parathyroid or thyroid surgery was performed (p = 0.003) independently predicted the use of more than ten OMEQs after surgery. A subgroup analysis was then performed on thyroidectomy-only patients.
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Conclusion. Overall, 93% of patients undergoing thyroidectomy and parathyroidectomy require 20 or fewer OMEQs by their postoperative visit. We therefore recommend these patients be discharged with 20 OMEQs, both to minimize waste and increase patient safety.
Thyroidectomy and parathyroidectomy are common endocrine operations, with demonstrated safety on an outpatient basis. [1] [2] [3] Our discharge criteria for ambulatory thyroidectomy include return to baseline activity, pain controlled on oral pain medications, the ability to tolerate a diet, void spontaneously with adequate social support, and understanding of instructions. Specific discharge criteria include assessment of the neck wound and voice. 2, 4 While several studies have examined the impact of timing 5 and types [6] [7] [8] of local anesthesia during thyroidectomy or parathyroidectomy on postoperative pain, the primary endpoints have focused on minimizing the use of intravenous narcotics while the patient remains in the hospital. However, most patients undergoing thyroid or parathyroid surgery are now discharged on the day of surgery and, to our knowledge, no data exist regarding the outpatient postoperative narcotic pain requirements for these patients or on predictors of such needs. With no guidance, the prescribed medications, doses, and quantities are commonly left to the discretion of the discharging physician or provider.
Increasing trends of unintentional drug poisoning in the US, especially from opioid analgesics, is currently at the forefront of the public health agenda. 9 Additionally, as care pathways are increasingly being developed and used, a standardization of outpatient prescribing practices would be helpful. This would permit more precise preoperative patient education and limit potential risks associated with the overprescription of opioids, such as drug sharing, abuse and overdose. In addition, standardization can assist providers in detecting excessive pain medication requirements, which may be indicative of a postoperative complication.
The primary aim of this study was to examine the outpatient narcotic medication requirement after thyroid and parathyroid surgery at two large endocrine surgery centers. Our secondary aim was to identify factors that could be predictive of requiring more than ten oral morphine equivalents (OMEQs).
MATERIAL AND METHODS
A total of 313 consecutive patients over the age of 18 years were identified as undergoing thyroid or parathyroid surgery between 1 January and 31 May 2014. Operations were performed at one of two large academic medical centers-the University of Rochester or the University of Wisconsin-by four endocrine surgeons. All operations were carried out under general anesthesia, supplemented with local anesthetic. Postoperative pain was assessed via a visual analog scale at three time points: on postoperative day (POD) 0, POD 1, and at their postoperative follow-up visit, which usually occurs 2 weeks after surgery. Pain scores from POD 1 were obtained retrospectively at the time of postoperative follow-up for those patients who were discharged the same day, and prospectively if the patient was monitored overnight. The overall mean pain score from these three encounters were then calculated for comparison.
At the postoperative visit, patients self-reported the number of narcotic tablets they had taken since surgery. This was incorporated into routine postoperative questions to minimize recall bias. As different types of oral narcotics were prescribed, all prescriptions were converted into OMEQs using an online calculator (Table 1) . 10 The OMEQ has been shown to better reflect clinical dosing and to provide greater insight into opioid consumption. 11 As 83% of our patient cohort required ten or fewer OMEQs, we chose more than ten OMEQs as the cut-off to define higher narcotic requirement. Patients were then stratified by more than or less than ten OMEQs and univariate analysis was performed. Categorical variables were analyzed using the Chi-square or Fisher's exact tests, and independent t-tests were used to compare continuous variables. Using preoperative and intraoperative factors, a multivariate logistic regression model was constructed to determine variables that could independently predict the use of more than ten OMEQs. Subgroup analysis further evaluated thyroidectomy patients. All statistical calculations were performed using SPSS version 22.0 (IBM SPSS Statistics for Windows; IBM Corporation, Armonk, NY, USA)
RESULTS

Patient Characteristics
Overall, 313 patients underwent thyroid and parathyroid surgery at two major academic medical centers. Partial or total thyroidectomy was performed in 166 (53%) cases, of which 48 (29%) were for thyroid cancer. Of 313 patients, 253 (81%) were female, with a mean length of stay of less than 1 day as most cases were performed on an outpatient basis. The average age of our cohort was 55 ± 0.85 years. Age was made a categorical variable using the cutoff of 45 years (the 25% quartile), and we found an association between younger age and higher OMEQ use (p \ 0.001) ( Table 2) .
Perioperative Factors
Patients underwent thyroid lobectomy, total thyroidectomy, unilateral or bilateral parathyroidectomy, or a combined operation including both thyroidectomy and parathyroidectomy. In most cases, the strap muscles were separated in the midline. Rarely in cases of large goiters, the straps were divided to facilitate exposure at the discretion of the surgeon, but we have no means of identifying which or how many of the patients had these muscles divided.
Our two centers differed in their intraoperative management algorithms. In one center, a single surgeon routinely performed pre-incision bilateral superficial cervical nerve blocks using 30 mL of 1% lidocaine and 0.25% bupivacaine. In the other center, three surgeons injected 20 or 30 mL of 0.25% bupivacaine into the incision prior to skin closure. Intraoperative analgesic medications were administered at the discretion of the anesthesia team. An ice pack was ordered for all patients postoperatively. On univariate analysis, whether thyroid or parathyroid surgery was performed (p \ 0.001), as well as the timing of injection of the local anesthetic (p \ 0.001), were associated with increased OMEQ requirement ( Table 2) .
Oral Morphine Equivalent Use
Hydrocodone/acetaminophen 5/325 mg (one OMEQ) was the most commonly prescribed oral narcotic medication, administered to 89.8% (281/313) of patients, followed OMEQs at discharge, with a range of 0-120. The median OMEQ taken was three (range 0-60), and the mode was zero (99/313, 31.6%). Only 7% of patients took more than 20 OMEQs (Fig. 1) . During the postoperative visit, patients were also asked to give a reason for taking prescription pain medication. Overall, 214 (68.4%) patients took at least one OMEQ after surgery, most commonly for incisional pain (60%). Interestingly, three patients (1%) reported taking narcotics because they were instructed to, despite having no pain (Fig. 2a) . Of the patients who took more than ten OMEQs, 46 (85%) reported doing so for incisional pain (Fig. 2b) .
Factors Predictive of Higher Narcotic Requirement
On univariate analysis, age \45 years (p \ 0.001), whether parathyroid or thyroid surgery was performed (p \ 0.001), timing of local anesthetic (p \ 0.001), the use of pain adjuncts (p = 0.002), and a prior history of narcotic use (p = 0.012) were associated with the use of more than ten OMEQs ( Table 2 ). The median age and interquartile range (IQR) of patients who required more than ten tablets was 46.5 (25.5-67.5), whereas the median age for patients who required ten or fewer OMEQs was 57 (40-74) (p \ 0.001; Fig. 3a) . Not surprisingly, patients who required more than ten OMEQs also reported higher mean pain scores (p \ 0.001) (Fig. 3b) .
We also found a center effect on outpatient OMEQ needs (p \ 0.001). As we could not determine whether this difference was due to nursing care or instructions, the timing or amount of local anesthetic administration, or from the overall random effects of two different centers, we adjusted for institution in our model. Our multivariate logistic regression model found that age less than 45 years [p = 0.002; odds ratio (OR) 0.31, 95% confidence interval (CI) 0.15-0.65], whether parathyroid or thyroid surgery was performed (p = 0.003; OR 0.31, 95% CI 0.14-0.66), and a history of previous narcotic use (p = 0.037; OR 4.15, (Table 2) .
Subgroup Analysis of Thyroidectomy Patients
Thyroidectomy was associated with more than ten OMEQs, therefore a subgroup analysis looking at these patients was performed. Limited sample size precluded a similar examination of parathyroidectomy patients, and four patients who underwent both parathyroidectomy and thyroidectomy were also excluded. Overall, 162 patients underwent thyroid surgery, with 40 patients reporting more than ten OMEQs (Table 3) . Looking exclusively at thyroidectomy patients also allowed inclusion of additional perioperative variables such as a cancer diagnosis, neck dissection, and drain use. Our multivariate model on thyroidectomy patients revealed that age \45 years (p = 0.004; OR 0.28, 95% CI 0.12-0.67) and total thyroidectomy (p = 0.031; OR 0.36, 95% CI 0.14-0.91) were predictive of higher OMEQ use (Table 3) .
DISCUSSION
The vast majority of patients undergoing thyroidectomy and parathyroidectomy demonstrated a minimal requirement for outpatient narcotics, with 93% of patients requiring 20 or fewer OMEQs. The overall mean pain score after surgery was 2 (IQR 0-4), indicating mild pain, if any, by the first postoperative visit. We also discovered that even between our two institutions, there was no standard prescribing pattern, with a wide range of prescriptions and number of equivalents dispensed. Based on our results, we have changed our practices to discharge all patients undergoing parathyroid or thyroid surgery and to request an oral narcotic prescription with no more than 20 equivalents, Standardizing prescribing practices for these commonly performed endocrine operations will not only reduce waste but also promote patient safety. The abuse and misuse of prescription narcotics is of continued public health concern, with opioids as the leading reason behind deaths from overdose in the US. 12 The rise in unintentional deaths from prescription drugs have paralleled the increase in opioid sales across the US. 9 This not only harms the narcotic user but also results in inadvertent exposure of small children from having such medications in the home. Additionally, by prescribing a median of 30 OMEQs to our patients, we may have been influencing expectations of the amount of postoperative pain. Previous studies evaluating pain after thyroidectomy have focused on reducing postoperative pain with different adjuncts, most commonly with the use of local anesthetic. Several double-blind, randomized studies have evaluated the role of bilateral superficial cervical plexus blocks in thyroidectomy with conflicting results. 6, 14 Despite differing study designs, these studies highlight the lack of consensus in terms of ideal volumes and types of local anesthetic used in thyroid surgery. The literature has also examined different concentrations of local anesthetic, as well as the timing of injection. Herbland et al. conducted a randomized trial evaluating the timing of bilateral superficial cervical plexus blocks using 0.75% ropivacaine with epinephrine injected either prior to incision or after thyroidectomy completion. 8 That study concluded that the addition of local anesthetic did not improve postoperative pain control in either the proportion of patients requiring postoperative analgesia or in the total amount of narcotics required. However, all of the aforementioned studies used inpatient intravenous morphine as the primary endpoint to assess analgesic effect but failed to examine the amount of oral narcotics required once the patient was discharged. A formal evaluation on the timing of local anesthetic during thyroid and parathyroid surgery in effecting postoperative outpatient pain requirements has yet to be performed.
As pain is subjective, it remains challenging to evaluate and treat. Several clinical trials have examined the role of varying adjuncts to narcotics in providing acceptable analgesia. Preemptive anesthesia remains controversial regarding its effectiveness with respect to postprocedural pain. 15 A randomized trial demonstrated decreases in postoperative pain scores and intravenous morphine use in patients who received gabapentin 2 h prior to thyroidectomy or parathyroidectomy. 16 Another trial explored the effect of music therapy on same-day inguinal herniorrhaphy patients and found a significant decrease in plasma cortisol levels in those who received music postoperatively compared with the control group. 17 A recent randomized study demonstrated the effectiveness of ice packs in reducing postoperative pain and morphine use in patients undergoing laparotomy. 18 Other non-opioid analgesics include over-the-counter medications such as ibuprofen, and acupuncture. 19 In our study, patients who required more than ten OMEQs were significantly more likely to use adjunctive measures; however, the impetus to do so is unclear.
Our study has several limitations. First, we included the breadth of endocrine neck operations from minimally invasive parathyroidectomy to total thyroidectomy with neck dissection. Parathyroidectomy patients likely require even fewer OMEQs than thyroidectomy patients; however, the number of parathyroidectomy patients reporting more than ten OMEQs did not allow further analysis. Second, the use of non-opioid analgesics is certainly a potential confounder to not only the reported pain scores but also the number of OMEQs taken; this was not specifically examined in this study. Although our study is unable to draw any specific conclusions on the role of adjunctive measures in treating postoperative pain, this is an important subject for future work. Our analysis also revealed institutional differences, for which the exact cause cannot be discerned but was adjusted for in our predictive modeling. Performance of a cervical plexus block as related to pain is a clear confounder; however, as the two institutions were complete opposites in practice, this variable could not be specifically examined. Additionally, we had missing data on previous narcotic use and limited availability of past psychiatric history, both of which have been associated with higher narcotic requirements and higher reported pain scores. 20 Lastly, although our data on pain scores and OMEQs taken was prospectively collected, the information was based on patient recollection and was analyzed in a retrospective manner. Notwithstanding these limitations, our study is the first to examine outpatient narcotic pain medication use after thyroid and parathyroid surgery. A standardized practice of prescribing stands to increase patient safety and minimize the risks of dependence and overdose. We found that 97% of patients used 20 OMEQs or less and that this number was inclusive of most patients. Reduced waste is also one of the ways prescribing providers can help control healthcare costs. In addition, our adjusted data from two large academic centers of varying geographic location make these recommendations more generalizable. Our findings in OMEQs are also translatable to whichever oral narcotic individual providers are most comfortable prescribing.
CONCLUSIONS
Overall, 93% of patients across two large academic institutions required 20 or fewer OMEQs after thyroid or parathyroid surgery, and nearly one-third of patients required none. Age \45 years, thyroid surgery, and a previous history of narcotic use were independent predictors on multivariate analysis for more than ten OMEQs. Therefore, patients undergoing thyroid and parathyroid surgery should be prescribed 20 OMEQs to minimize waste and to increase patient safety.
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